Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Sioufi

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Clinical Chemistry and Laboratory Medicine|November 11, 2024
Navigation between EQA and sustainabilityTony Badrick, Zoe Vayanos, John Sioufi
Clinical Chemistry and Laboratory Medicine|September 23, 2025
Does patient-based data monitoring allow us to reconsider the relationship between IQC and EQA?Tony Badrick, John Sioufi, Derek Holzhauser
Pathology|May 5, 2015
The effect of dabigatran on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samplesRoslyn Bonar, Emmanuel J Favaloro, Soma Mohammed, et al.
Seminars in Thrombosis and Hemostasis|February 20, 2010
Investigations from external quality assurance programs reveal a high degree of variation in the laboratory identification of coagulation factor inhibitorsEmmanuel J Favaloro, Roslyn Bonar, Geoffrey Kershaw, et al.
Pathology|March 30, 2016
The effect of the direct factor Xa inhibitors apixaban and rivaroxaban on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samplesRoslyn Bonar, Emmanuel J Favaloro, Soma Mohammed, et al.
Laboratory Hematology : Official Publication of the International Society for Laboratory Hematology|January 15, 2008
The diagnostic dilemma: dual presentations of clinical mucosal bleeding and venous thrombosis associated with the presence of thrombophilia markers and mild reduction in von Willebrand factorEmmanuel J Favaloro, Roslyn Bonar, Lesley Survela, et al.
American Journal of Clinical Pathology|June 24, 2003
Laboratory diagnosis of von Willebrand disorder. Current practice in the southern hemisphereEmmanuel J Favaloro, Roslyn Bonar, John Sioufi, et al.
Thrombosis Research|June 11, 2014
Evaluating errors in the laboratory identification of von Willebrand disease in the real worldEmmanuel J Favaloro, Roslyn A Bonar, Muriel Meiring, et al.
Seminars in Thrombosis and Hemostasis|July 25, 2006
Reducing errors in identification of von Willebrand disease: the experience of the royal college of pathologists of australasia quality assurance programEmmanuel J Favaloro, Roslyn Bonar, Geoff Kershaw, et al.
Laboratory Hematology : Official Publication of the International Society for Laboratory Hematology|September 22, 2005
How useful is the monitoring of (low molecular weight) heparin therapy by anti-Xa assay? A laboratory perspectiveEmmanuel J Favaloro, Roslyn Bonar, Margaret Aboud, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Clinical Chemistry and Laboratory Medicine|November 11, 2024
Navigation between EQA and sustainabilityTony Badrick, Zoe Vayanos, John Sioufi
Clinical Chemistry and Laboratory Medicine|September 23, 2025
Does patient-based data monitoring allow us to reconsider the relationship between IQC and EQA?Tony Badrick, John Sioufi, Derek Holzhauser
Pathology|May 5, 2015
The effect of dabigatran on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samplesRoslyn Bonar, Emmanuel J Favaloro, Soma Mohammed, et al.
Seminars in Thrombosis and Hemostasis|February 20, 2010
Investigations from external quality assurance programs reveal a high degree of variation in the laboratory identification of coagulation factor inhibitorsEmmanuel J Favaloro, Roslyn Bonar, Geoffrey Kershaw, et al.
Pathology|March 30, 2016
The effect of the direct factor Xa inhibitors apixaban and rivaroxaban on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samplesRoslyn Bonar, Emmanuel J Favaloro, Soma Mohammed, et al.
Laboratory Hematology : Official Publication of the International Society for Laboratory Hematology|January 15, 2008
The diagnostic dilemma: dual presentations of clinical mucosal bleeding and venous thrombosis associated with the presence of thrombophilia markers and mild reduction in von Willebrand factorEmmanuel J Favaloro, Roslyn Bonar, Lesley Survela, et al.
American Journal of Clinical Pathology|June 24, 2003
Laboratory diagnosis of von Willebrand disorder. Current practice in the southern hemisphereEmmanuel J Favaloro, Roslyn Bonar, John Sioufi, et al.
Thrombosis Research|June 11, 2014
Evaluating errors in the laboratory identification of von Willebrand disease in the real worldEmmanuel J Favaloro, Roslyn A Bonar, Muriel Meiring, et al.
Seminars in Thrombosis and Hemostasis|July 25, 2006
Reducing errors in identification of von Willebrand disease: the experience of the royal college of pathologists of australasia quality assurance programEmmanuel J Favaloro, Roslyn Bonar, Geoff Kershaw, et al.
Laboratory Hematology : Official Publication of the International Society for Laboratory Hematology|September 22, 2005
How useful is the monitoring of (low molecular weight) heparin therapy by anti-Xa assay? A laboratory perspectiveEmmanuel J Favaloro, Roslyn Bonar, Margaret Aboud, et al.
Pageof 2